Controlling robotic prostheses with one’s mind has been a hot topic in research, but making a prothesis ‘talk back’ has been a stumbling block. Researchers from Switzerland show progress in creating
Medical Research
The Austrian Centre of Industrial Biotechnology (acib) and GE Healthcare are introducing a cell line engineering research collaboration to bring increased productivity to biomanufacturers The goal of the three-year partnership
Roche’s oral ALK inhibitor, Alecensa, has been conditionally approved in the European Union as a monotherapy for anaplastic lymphoma kinase-positive advanced non-small cell lung cancer (NSCLC) in adults who were
Lanthio Pharma has initiated a Phase I clinical trial with its lanthipeptide candidate MOR107, which is being developed as a therapy for diabetic nephropathy. Lanthio Pharma, a Dutch subsidiary of
Scientists at Emory University’s Winship Cancer Institute are on a mission to unlock the mysteries of lung cancer cells that have long been thought to be unresponsive to any drug
Researchers at Eindhoven University of Technology (TU/e) present a new method that should enable controlled drug delivery into the bloodstream using DNA computers. In the journal Nature Communications the team,
Cambridge Research Biochemicals (CRB), specialist in the synthesis of custom peptides and antibody production has announced the release of its new Discovery Antibodies catalogue. The company’s new product range will offer the
Strong product pipeline will drive double-digit growth rates in the Western Europe and US markets, finds Frost & Sullivan’s Transformational Health team The emerging cardiac therapies market in the US
Faron Pharmaceuticals has recruited its first patient to a phase II clinical trial of its lead drug, Traumakine, in the treatment of organ failure after a ruptured abdominal aorta aneurysm
UK-based rare and speciality diseases group Mereo BioPharma says its brittle bone disease drug BPS-804 has been accepted to participate in the European Medicines Agency’s (EMA) Adaptive Pathways programme. The
Sartorius announced on Feb. 17, 2017 that it was partnering with the European Molecular Biology Laboratory (EMBL) research institute to advance scientific training and education. Sartorius will lend its expertise to
Modus Therapeutics has raised €3.4M to support the completion of a Phase II trial for sickle cell disease, a painful condition with no cure. Modus Therapeutics, previously Dilaforette, is developing sevuparin,
People living in Ayrshire and Arran who have some of the most common forms of avoidable sight loss will now be able to benefit from a new facility designed specifically
Roche’a anticipated approval of ocrelizumab will drive the company’s share of the market from <1% in 2016 to 15% by 2022, according to GBI Research The company’s report states that
The University of Liverpool, in partnership with AKL Research and Development, will lead a clinical trial testing the potential of a new therapy for osteoarthritis (OA), the most common type
Originally projected to be on the market by 2020, excitement about the contact lens to measure glucose levels from Novartis and Google has waned. Why? In 2016, smart wearables growth was steady but
Merck & Co has terminated a Phase II/III trial testing its investigational medicine verubecestat in patients with mild to moderate Alzheimer’s disease. The move came after an external data monitoring
A new biologic agent – the most potent of its kind so far – is showing early promise as part of a potential new strategy for treating HIV. The drug,
Johnson & Johnson is counting on new buy Actelion’s pulmonary arterial hypertension (PAH) meds to provide a top-line boost once its $30 billion transaction closes. But one of them may
By hijacking a cancer cell’s own metabolism, researchers have found a way to tag and target elusive cancers with small-molecule sugars. This opens treatment pathways for cancers that are not
Multiple pharmaceutical companies have signed on to participate in a £14-million (approximately $17.47-million) research project focused on drug safety, according to a Jan. 29, 2017 press announcement. The project will
One of Europe’s largest collaborative academic-industry research projects, designed to develop and assess novel approaches for identification of new markers for colon cancer, has been conducted by public-private consortium OncoTrack.
The European Commission (EC) has granted marketing authorisation in Europe for Sanofi‘s Suliqua, a titratable fixed-ratio combination of basal insulin
The US Food and Drug Administration (FDA) has authorised Abbott’s molecular test to detect Zika virus in whole blood (when
As recently published in the International Journal of Cancer, researchers from Breast-Predict, may have found a new drug for the
Advertisements
